tiprankstipranks
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
US Market

Vaxcyte (PCVX) Income Statement

Compare
336 Followers

Vaxcyte Income Statement

Last quarter (Q4 2024), Vaxcyte's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Vaxcyte's net income was $-137.08M. See Vaxcyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -75.00M$ -9.20M$ -1.80M$ -1.41M
Operating Expenses
$ 569.55M$ 468.04M$ 207.33M$ 102.08M$ 87.10M
Depreciation and Amortization
$ 0.00$ 3.16M$ 9.20M$ 1.80M$ 1.41M
EBITDA
$ -569.55M$ -464.88M$ -214.29M$ -98.28M$ -87.81M
Operating Income
$ -569.55M$ -468.04M$ -232.26M$ -103.67M$ -89.58M
Other Income/Expenses
$ 105.62M$ 65.78M$ 8.77M$ 3.59M$ 364.00K
Pretax Income
$ -463.93M$ -402.27M$ -223.49M$ -100.08M$ -89.22M
Net Income
$ -463.93M$ -402.27M$ -239.64M$ -100.08M$ -87.82M
Per Share Metrics
Basic EPS
$ -3.80$ -4.14$ -3.69$ -1.93$ -1.72
Diluted EPS
$ -3.80$ -4.14$ -3.69$ -1.93$ -1.72
Weighted Average Shares Outstanding
122.00M 97.16M 64.88M 51.92M 51.07M
Weighted Average Shares Outstanding (Diluted)
122.00M 97.16M 64.88M 51.92M 51.07M
Currency in USD

Vaxcyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis